Helicobacter pylori infection and gastroduodenal lesions in patients with systemic lupus erythematosus-Reference-Cited by-同舟云学术

Helicobacter pylori infection and gastroduodenal lesions in patients with systemic lupus erythematosus

Published:2019-11-12 Issue:2 Volume:39 Page:463-469
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Mendoza-Pinto Claudia^ORCID,García-Carrasco Mario^ORCID,Méndez-Martínez Socorro,Mogollán-Delfín Tania,Munguía-Realpozo Pamela,Herrera-Robles Efrén,Etchegaray-Morales Ivet,Gálvez-Romero José Luis,Montiel-Jarquín Álvaro^ORCID,López-Colombo Aurelio

Funder

Instituto Mexicano del Seguro Social

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-019-04805-w.pdf

Reference34 articles.

1. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ (1985) Attempt to fulfil Koch’s postulates for pyloric Campylobacter. Med J Aust 142:436–439

2. Chan FK, Sung JJ, Chung SC et al (1997) Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet (London, England) 350:975–979

3. Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, Sturrock RD, Russell RI (1999) Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology 116:254–258